Enhancement of Diabetic Retinopathy Prognostication Using Deep Learning, CLAHE, and ESRGAN

Diagnostics (Basel). 2023 Jul 14;13(14):2375. doi: 10.3390/diagnostics13142375.

Abstract

One of the primary causes of blindness in the diabetic population is diabetic retinopathy (DR). Many people could have their sight saved if only DR were detected and treated in time. Numerous Deep Learning (DL)-based methods have been presented to improve human analysis. Using a DL model with three scenarios, this research classified DR and its severity stages from fundus images using the "APTOS 2019 Blindness Detection" dataset. Following the adoption of the DL model, augmentation methods were implemented to generate a balanced dataset with consistent input parameters across all test scenarios. As a last step in the categorization process, the DenseNet-121 model was employed. Several methods, including Enhanced Super-resolution Generative Adversarial Networks (ESRGAN), Histogram Equalization (HIST), and Contrast Limited Adaptive HIST (CLAHE), have been used to enhance image quality in a variety of contexts. The suggested model detected the DR across all five APTOS 2019 grading process phases with the highest test accuracy of 98.36%, top-2 accuracy of 100%, and top-3 accuracy of 100%. Further evaluation criteria (precision, recall, and F1-score) for gauging the efficacy of the proposed model were established with the help of APTOS 2019. Furthermore, comparing CLAHE + ESRGAN against both state-of-the-art technology and other recommended methods, it was found that its use was more effective in DR classification.

Keywords: APTOS; Deep Learning; blindness; diabetic retinopathy; transfer learning.